Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication

被引：27

作者：

Slater, MJ ^{[1
]}

Baxter, R ^{[1
]}

Bonser, RW ^{[1
]}

Cockerill, S ^{[1
]}

Gohil, K ^{[1
]}

Parry, N ^{[1
]}

Robinson, E ^{[1
]}

Randall, R ^{[1
]}

Yeates, C ^{[1
]}

Snowden, W ^{[1
]}

Walters, A ^{[1
]}

机构：

[1] GlaxoSmihKline, Med Res Ctr, Stevenage SG1 2NY, Herts, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 15期

关键词：

D O I：

10.1016/S0960-894X(01)00352-3

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and antiviral evaluation of unsymmetrical indolocarbazole derivatives of Arcyriaflavin A, substituted with a range of alkyl groups at the indole nitrogen, is described. Structure-activity relationships in this series against human cytomegalovirus (HCMV) replication in cell culture are reported. Compound 4b was identified as potent inhibitor of HCMV (IC50 = 19 nM), which retained activity against a range of HCMV strains including ganciclovir resistant isolates. (C) 2001 Elsevier Science Ltd. All rights reserved.

引用

页码：1993 / 1995

页数：3

共 24 条

[11] CHARACTERISTICS OF CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
HEINEMANN, MH
[J]. AMERICAN JOURNAL OF MEDICINE, 1992, 92 : S12 - S16
[12] Therapeutic developments in cytomegalovirus retinitis
Hoffman, VF
Skiest, DJ
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (02) : 207 - 220
[13] SERIOUS CYTOMEGALO-VIRUS DISEASE IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
JACOBSON, MA
MILLS, J
[J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) : 585 - 594
[14] PHASE I/II STUDY OF INTRAVITREAL CIDOFOVIR FOR THE TREATMENT OF CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
KIRSH, LS
AREVALO, JF
DECLERCQ, E
CHAVEZ, E
MUNGUIA, D
GARCIA, R
FREEMAN, WR
[J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 119 (04) : 466 - 476
[15] Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
Komanduri, KV
Viswanathan, MN
Wieder, ED
Schmidt, DK
Bredt, BM
Jacobson, MA
McCune, JM
[J]. NATURE MEDICINE, 1998, 4 (08) : 953 - 956
[16] Staurosporine and ent-staurosporine: The first total syntheses, prospects for a regioselective approach, and activity profiles
Link, JT
Raghavan, S
Gallant, M
Danishefsky, SJ
Chou, TC
Ballas, LM
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (12) : 2825 - 2842
[17] RISK-FACTORS FOR CYTOMEGALOVIRUS-INFECTION AFTER HUMAN MARROW TRANSPLANTATION
MEYERS, JD
FLOURNOY, N
THOMAS, ED
[J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) : 478 - 488
[18] Pindur U, 1999, CURR MED CHEM, V6, P29
[19] ANTICYTOMEGALOVIRAL ACTIVITY AND SAFETY OF CIDOFOVIR IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CYTOMEGALOVIRUS VIRURIA
POLIS, MA
SPOONER, KM
BAIRD, BF
MANISCHEWITZ, JF
JAFFE, HS
FISHER, PE
FALLOON, J
DAVEY, RT
KOVACS, JA
WALKER, RE
WHITCUP, SM
NUSSENBLATT, RB
LANE, HC
MASUR, H
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) : 882 - 886
[20] Qu XG, 1999, ANTI-CANCER DRUG DES, V14, P433

← 1 2 3 →